Knight Therapeutics | GUD - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Acasti Pharma USD 18.67M 1.81M 2025-12
Akebia Therapeutics USD 155.55M 7.1M 2026-06
Alaunos Therapeutics USD 354K 1.03M 2026-03
Aurora Cannabis CAD 64.69M 8.33M 2026-03
Avita Medical AUD 10.24M 1.98M 2025-12
Canopy Growth CAD 364.68M 6.64M 2026-03
Cronos Group USD 467.02M 354.84M 2026-06
Dianthus Therapeutics USD 110.55M 517.12M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
IQVIA Holdings USD 1.91B 38M 2026-06
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Moderna USD 1.72B 185M 2026-06
Omeros USD 1.9M 2.36M 2025-06
Organigram Holdings CAD 4.29M 3.28M 2026-03
Organon & Co USD 1.13B 16M 2026-06
Revvity USD 1.02B 162.62M 2026-06
Tectonic Therapeutic USD 236.89M 16.9M 2026-03
Tilray USD 264.83M 43.16M 2025-06
Viatris USD 886.5M 917.7M 2026-06
Xeris Pharmaceuticals USD 121.75M 10M 2026-06